Review of Slovenia's Economy from 19 to 25 October
Ljubljana, 27 October - The Swiss pharma company Novartis raised its offer for the takeover of Slovenian drug maker Lek to EUR 459, prompting Lek's major shareholders to agree to sell all Lek shares at the price and sending the Slovenian benchmark SBI 20 index flying. On the contrary, the second phase of privatisation of Nova Ljubljanska banka (NLB) looks rather gloomy, as Slovenian portfolio investors submitted bids for as little as 0.3 percent of the country's largest bank, while nine percent of NLB was up for sale to domestic investors.
The rest of this news item is available to subscribers.
The news item consists of 5.942 characters (without spaces) or 1.131 words words.
Buy the news item. Price: 10 tokens; on account: 0 tokens.